InsiderClue
Insiders · Profile

PACE GARY W

Director at Cardiff Oncology · Director at Pacira BioSciences · Director at ResMed| · and 1 more. Filing since 6 Mar 2007. CIK 0001184778

CRDF Cardiff Oncology, Inc. Director · 15 trades PCRX Pacira BioSciences, Inc. Director · 11 trades RMD ResMed| Director · 18 trades IMNN Imunon, Inc. Director · 3 trades
Company
Date
Role
Action
Shares
Amount
Of holding
CRDF Cardiff Oncology, Inc.
14 Jul 2026
Director
Bought
687,285
$1,000.00K
50.7%
CRDF Cardiff Oncology, Inc.
18 Jun 2026
Director
Bought
30,000
$36.60K
2.3%
CRDF Cardiff Oncology, Inc.
30 Jul 2025
Director
Bought
275,000
$673.75K
26.0%
CRDF Cardiff Oncology, Inc.
30 Jul 2025
Director
Bought
15,000
$36.75K
1.1%
CRDF Cardiff Oncology, Inc.
11 Dec 2024
Director
Bought
350,115
$910.30K
50.2%
CRDF Cardiff Oncology, Inc.
11 Dec 2024
Director
Bought
11,500
$29.90K
1.1%
PCRX Pacira BioSciences, Inc.
8 Mar 2024
Director
Sold at will
90,000
$2.75M
80.3%
PCRX Pacira BioSciences, Inc.
7 Mar 2024
Director
Sold at will
28,257
$870.60K
20.1%
PCRX Pacira BioSciences, Inc.
6 Mar 2024
Director
Sold at will
1,066
$31.63K
0.8%
CRDF Cardiff Oncology, Inc.
19 Dec 2023
Director
Bought
30,000
$41.10K
4.5%
CRDF Cardiff Oncology, Inc.
10 Nov 2023
Director
Bought
22,950
$22.49K
3.6%
PCRX Pacira BioSciences, Inc.
11 May 2023
Director
Sold at will
5,015
$209.53K
3.5%
CRDF Cardiff Oncology, Inc.
15 Sep 2022
Director
Bought
150,000
$256.50K
30.3%
PCRX Pacira BioSciences, Inc.
1 Mar 2022
Director
Sold, plan not stated
1,359
$92.07K
1.0%
PCRX Pacira BioSciences, Inc.
28 Feb 2022
Director
Sold, plan not stated
28,641
$1.91M
18.1%
CRDF Cardiff Oncology, Inc.
21 Sep 2021
Director
Bought
30,000
$202.50K
6.5%
CRDF Cardiff Oncology, Inc.
23 Mar 2021
Director
Bought
10,000
$102.30K
2.2%
CRDF Cardiff Oncology, Inc.
18 Mar 2021
Director
Bought
3,000
$31.66K
0.7%
CRDF Cardiff Oncology, Inc.
4 Mar 2021
Director
Bought
1,500
$13.90K
0.3%
CRDF Cardiff Oncology, Inc.
16 Sep 2020
Director
Bought
2,550
$14.53K
0.6%
CRDF Cardiff Oncology, Inc.
11 May 2020
Director
Bought
447,761
$600.00K
opened
PCRX Pacira BioSciences, Inc.
19 Nov 2018
Director
Bought
4,500
$207.81K
15.9%
PCRX Pacira BioSciences, Inc.
7 Nov 2018
Director
Bought
4,000
$205.16K
16.4%
RMD ResMed|
8 May 2018
Director
Sold, plan not stated
28,403
$2.77M
22.0%
RMD ResMed|
15 Jun 2017
Director
Sold, plan not stated
22,660
$1.72M
18.8%
RMD ResMed|
14 Jun 2017
Director
Sold, plan not stated
1,730
$131.48K
1.7%
RMD ResMed|
19 Aug 2016
Director
Sold, plan not stated
36,000
$2.52M
27.9%
RMD ResMed|
11 Mar 2016
Director
Sold, plan not stated
36,000
$2.16M
27.9%
PCRX Pacira BioSciences, Inc.
13 Mar 2015
Director
Bought
1,000
$93.83K
5.7%
RMD ResMed|
26 Jan 2015
Director
Sold, plan not stated
48,000
$3.20M
34.0%
RMD ResMed|
18 Aug 2014
Director
Sold, plan not stated
25,000
$1.29M
22.1%
RMD ResMed|
18 Feb 2014
Director
Sold, plan not stated
48,000
$2.21M
38.3%
RMD ResMed|
9 Sep 2013
Director
Bought
12,000
$600.61K
18.4%
RMD ResMed|
7 Aug 2012
Director
Sold, plan not stated
48,000
$1.73M
38.3%
PCRX Pacira BioSciences, Inc.
17 Apr 2012
Director
Bought
10,000
$97.50K
130%
RMD ResMed|
27 Jan 2012
Director
Sold, plan not stated
48,000
$1.44M
38.3%
PCRX Pacira BioSciences, Inc.
21 Nov 2011
Director
Bought
7,692
$50.00K
opened
RMD ResMed|
22 Jun 2011
Director
Bought
64,000
$1.99M
482%
RMD ResMed|
19 Feb 2010
Director
Sold, plan not stated
32,000
$1.83M
16.9%
RMD ResMed|
11 May 2009
Director
Sold, plan not stated
10,666
$426.13K
6.3%
IMNN Imunon, Inc.
4 Dec 2008
Director
Bought
19,007
$47.51K
78.1%
IMNN Imunon, Inc.
26 Feb 2008
Director
Bought
4,000
$25.08K
19.7%
IMNN Imunon, Inc.
25 Feb 2008
Director
Bought
2,000
$12.34K
10.9%
RMD ResMed|
9 Mar 2007
Director
Sold, plan not stated
1,600
$75.42K
1.0%
RMD ResMed|
8 Mar 2007
Director
Sold, plan not stated
4,400
$208.00K
2.7%
RMD ResMed|
7 Mar 2007
Director
Sold, plan not stated
3,000
$141.83K
1.8%
RMD ResMed|
6 Mar 2007
Director
Sold, plan not stated
6,000
$277.65K
3.5%
47 decisions on file.